| Schedule of profit or loss and total assets for each reportable segment |
Three Months Ended November 30, 2023 |
|
IP Licensing |
|
|
B2B Product |
|
|
R&D |
|
|
Corporate |
|
|
Consolidated Total |
|
| Revenue |
|
$ |
144,990 |
|
|
$ |
5,388 |
|
|
$ |
900 |
|
|
$ |
- |
|
|
$ |
151,278 |
|
| Cost of goods sold |
|
|
- |
|
|
|
(4,822 |
) |
|
|
- |
|
|
|
- |
|
|
$ |
(4,822 |
) |
| Operating expenses |
|
|
(41,478 |
) |
|
|
(54,169 |
) |
|
|
(586,605 |
) |
|
|
(603,345 |
) |
|
$ |
(1,285,597 |
) |
| Other Income(Expense) |
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
(45,897 |
) |
|
$ |
(45,897 |
) |
| Segment loss |
|
$ |
103,512 |
|
|
$ |
(53,603 |
) |
|
$ |
(585,705 |
) |
|
$ |
(649,242 |
) |
|
$ |
(1,185,038 |
) |
| Total assets |
|
$ |
132,627 |
|
|
$ |
63,573 |
|
|
$ |
76,245 |
|
|
$ |
3,354,327 |
|
|
$ |
3,626,773 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended November 30, 2022 |
|
IP Licensing |
|
|
B2B Product |
|
|
R&D |
|
|
Corporate |
|
|
Consolidated Total |
|
| Revenue |
|
$ |
63,435 |
|
|
$ |
29,100 |
|
|
$ |
5,200 |
|
|
$ |
- |
|
|
$ |
97,735 |
|
| Cost of goods sold |
|
|
- |
|
|
|
(15,795 |
) |
|
|
- |
|
|
|
- |
|
|
$ |
(15,795 |
) |
| Operating expenses |
|
|
(707,034 |
) |
|
|
(10,992 |
) |
|
|
(829,489 |
) |
|
|
(229,844 |
) |
|
$ |
(1,777,359 |
) |
| Other Income(Expense) |
|
|
|
|
|
|
- |
|
|
|
- |
|
|
|
(73,887 |
) |
|
$ |
(73,887 |
) |
| Segment loss |
|
$ |
(643,599 |
) |
|
$ |
2,313 |
|
|
$ |
(824,289 |
) |
|
$ |
(303,731 |
) |
|
$ |
(1,769,306 |
) |
| Total assets |
|
$ |
118,096 |
|
|
$ |
75,723 |
|
|
$ |
136,564 |
|
|
$ |
5,883,097 |
|
|
$ |
6,213,480 |
|
|